Elutia

ELUTNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$35.883 M

$0.81 -5.06%

Close of 22 Sept 2026

Revenue

—

Not reported

Earnings

$53.4M

#1542 by earnings

Shares outstanding

—

Latest filing cover page

P/E ratio

0.7

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 160 →

#131ScilexSCLX$45.4M
#132Metagenomi TherapeuticsMGX$43.1M
#133ElutiaELUT$35.9M
#134Aligos TherapeuticsALGS$35.5M
#135Atyr PharmaATYR$35.0M

What if Elutia were worth as much as…

Open the what-if tool →

Gold $30.2T

$682,648.35

Per share 842,568× higher

Bitcoin $1.74T

$39,324.57

Per share 48,537× higher

Nvidia $5.52T

$124,539.69

Per share 153,715× higher

Or at a round number

$50.0M $100.0M $200.0M $500.0M

Where these numbers come from

Share counts and financials for Elutia are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.